Stellum Capital and Inveready acquire minority stake in LEV 2050
Stellum Capital and Inveready Asset Management have acquired 25% of LEV 2050.
It is the seventh investment from the Stellum Food&Tech I fund, while Inveready invested from its Inveready Biotech IV...